SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Warns Shire Pharmaceuticals (JOBS), Eisai Company, Ltd. (JOBS) on Promotions

November 16, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. regulators have warned Shire PLC (SHP.L) and Eisai Co Ltd (4523.T) about drug promotions that minimized the medicines' risks and overstated benefits, letters released on Friday said.
Clinical research Postmarket research Legal Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Contemporary art collage of a hand holding scissors. Copy space for ad. Modern design.
Regulatory
Krystal Cuts Melanoma Study of Viral Immunotherapy as FDA ‘Uncertainty’ Muddies Approval Pathway
August 22, 2025
 · 
2 min read
 · 
Tristan Manalac
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
August 21, 2025
 · 
1 min read
 · 
Lori Ellis
The white plane flies against the blue sky, leaving a white trail. Vector illustration
Regulatory
Stealth’s Flight Path Returns to FDA for Rejected Barth Drug
August 21, 2025
 · 
1 min read
 · 
Annalee Armstrong
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac